About Us
Welcome to Dr. Mufti’s OncoPathology and Clinical Reference Laboratory, a beacon of innovation in the heart of Jammu and Kashmir.
Spearheaded by Dr. Suhail Sayeed Mufti, our laboratory is a trailblazer in the healthcare industry, introducing groundbreaking digital pathology solutions that redefine the possibilities of pathology in the region. Our commitment is not only to deliver accurate diagnostic services but also to revolutionize the healthcare landscape through constant innovation. Dr. Mufti’s OncoPathology is more than just a laboratory; it is a vision to set unprecedented milestones in cancer care.
1500+
Collection Centers
125+
Laboratories
50M+
Test Performed
7
Countries
Vision and Mission
At the core of our mission is the goal to revolutionize the healthcare industry by providing advanced digital pathology and molecular oncology solutions. We are introducing the first digital pathology scanner in Jammu and Kashmir, enabling superspecialty pathologists from across the country and the globe to provide primary or second opinions. Our services include AI-based pathology algorithms developed in collaboration with leading software companies, immunohistochemistry and molecular genomics services, and the establishment of the first cancer biobank in the region. With an emphasis on comprehensive pathology reporting and cutting-edge automation, we aim to expedite diagnoses, ensure precision, and enhance the overall diagnostic experience.
Moreover, our commitment to local youth development through training opportunities aligns with our vision of fostering economic growth and empowerment in Jammu and Kashmir. As we look ahead, our ambitious growth plan includes expanding our reach, introducing novel technologies, and making a lasting impact on the global healthcare map. Dr. Mufti’s OncoPathology is not just a laboratory; it’s a pioneering force driving the future of healthcare.
Chairman’s Message
Our dedication to precision diagnostics is reflected in every aspect of our services. We ensure accurate and quality diagnoses through our integrated pathology reporting system. The provision of 24×7 services underscores our commitment to timely and reliable healthcare.
As a for-profit social enterprise, we commit to reinvesting a major part of our profits towards preventive oncology. Recognizing the increasing global incidence of cancer, our investment in preventive oncology is a strategic move with potential socioeconomic gains for the future.
Dr. Mufti’s OncoPathology is committed to advanced technology, clinical research, and future growth. Our collaboration with Aindra Systems in Bangalore for digital pathology software development is a testament to our commitment to harnessing the power of artificial intelligence for cancer diagnosis. Our proprietary pathology reporting system, PathNexia, developed in partnership with Aindra Systems, is revolutionizing diagnostics worldwide.
Looking ahead, our future growth plan is ambitious, aiming to elevate the capabilities of the healthcare industry further. We envision expanding our reach, introducing novel technologies, and leaving an indelible mark on the global healthcare map.
In closing, what sets us apart is not just our services but our approach. We integrate histopathology, immunohistochemistry, cytogenetics, and genomics, offering a comprehensive pathology reporting system that enhances the overall diagnostic and research experience.
Dr. Mufti Suhail Sayeed
Dr. Beenish Nazir
MD’s Message
At Dr. Mufti’s OncoPathology, we don’t just provide services; we embody a vision—a commitment to revolutionizing healthcare through innovation. Our dedicated team, state-of-the-art infrastructure, and unwavering focus on research and development form the foundation of our success.
Dr. Mufti’s OncoPathology and Clinical Reference Laboratory